Entering text into the input field will update the search result below

NanoViricides net loss improves in FQ1

  • NanoViricides (NYSE:NNVC -3.2%) FQ1 results: Revenues: $0; R&D Expense: $0.8M (-33.3%); G&A: $0.9M (+28.6%); Operating Loss: ($1.7M) (+10.5%); Net Loss: ($0.2M) (+96.8%); EPS: $0 ;Quick Assets: $41.1M (12.0%).
  • No guidance given.

Recommended For You

More Trending News

About NNVC Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
NNVC--
NanoViricides, Inc.